| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2022 | May 31, 2022 | Salarius Pharmaceuticals, Inc. | CEO | Buy | 85.0 | +43,900 | 5.26% | ✗ | $8K |
| Mar 3, 2022 | Mar 9, 2022 | Salarius Pharmaceuticals, Inc. | CEO | Buy | 95.0 | +139,488 | 126.59% | ✗ | $54.5K |
| Aug 17, 2021 | Aug 17, 2021 | Salarius Pharmaceuticals, Inc. | CEO | Buy | 77.5 | +4,000 | 2.02% | ✗ | $3.6K |
| Aug 19, 2020 | Aug 20, 2020 | Salarius Pharmaceuticals, Inc. | CEO | Buy | 90.0 | +2,000 | 200.00% | ✗ | $2K |
| Feb 11, 2020 | Feb 12, 2020 | Salarius Pharmaceuticals, Inc. | CEO | Buy | 82.5 | +2,175 | 2.74% | ✗ | $2.5K |